Health Advance Inc. (HADV)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (25.00%)
At close: Aug 8, 2025
Health Advance Market Cap
Health Advance has a market cap or net worth of $146.66 thousand as of August 14, 2025. Its market cap has decreased by -69.66% in one year.
Market Cap
146.66K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 13, 2012, Health Advance's market cap has decreased from 343.80K to 146.66K, a decrease of -57.34%. That is a compound annual growth rate of -6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 146.66K | -48.36% |
| Dec 31, 2024 | 284.01K | -76.39% |
| Dec 28, 2023 | 1.20M | 17.64% |
| Dec 30, 2022 | 1.02M | -87.29% |
| Dec 31, 2021 | 8.05M | 215.00% |
| Dec 31, 2020 | 2.55M | 245.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 597.56M |
| Elite Pharmaceuticals | 567.50M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |